Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas

Cancer Research

Volumn 58, Issue 3, 1998, Pages 504-508

  Lee, Jung Young ^a   Dong, Seung Myung ^a   Park, Won Sang ^a,d   Yoo, Nam Jin ^a   Kim, Choo Soung ^a   Jang, Ja Jun ^b   Chi, Je Geun ^b   Zbar, Berton ^c   Lubensky, Irina A ^d   Linehan, W Marston ^d   Vortmeyer, Alexander O ^d   Zhuang, Zhengping ^d  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBELLUM TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; HEMANGIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; STROMA CELL; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 18844474899     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Maher, E. R. von Hippel-Lindau disease. Eur. J. Cancer, 30A: 1987-1990, 1994.
2. Choyke, P. L., Glenn, G. M., Walther, M. M., Patronas, N. J., Linehan, W. M., and Zbar, B. von Hippel-Lindau disease. Genetic, clinical, and imaging features. Radiology, 194: 629-642, 1995.
3. Seizinger, B. R., Rouleau, G. A., Ozelius, L. J., Lane, A. H., Farmer, G. E., Lamiell, J. M., Haines, J., Yuen, J. W. M., Collins, D., Majoor-Krakauer, D., Bonner, T., Mathew, C., Rubenstein, A., Halperin, J., McConkie-Rosell, A., Green, J. S., Trofatter, J. A., Ponder, B. A., Eierman, L., Bowmer, M. I., Schimke, R., Oostra, B., Aronin, N., Smith, D. I., Drabkin, H., Waziri, M. H., Hobbs, W. J., Martuza, R. L., Conneally, P. M., Hsia, Y. E., and Gusella, J. F. von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature (Lond.), 332: 268-269, 1988.
4. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Mosi, W., Geil, L., Schmidt, L., Zhou, F., Li, H., Wei, M. H., Chen, F., Glenn, G., Choyke, P., Walther, M. M., Weng, Y., Duan, D. R., Glavac, D., Richards, F. M., Crossey, P. A., Ferguson-Smith, M. A., Palier, D. L., Chumkov, I., Cohen, D., Chinault, C., Mather, E. R., Linehan, W. M., Zbar, B., and Lerman, M. I. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science (Washington DC), 260: 1317-1320, 1993.
5. Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duch, F. M., Lubensky, L. Duan, D. R., Florence, C., Pozzatti, R., Walther, M. M., Bander, N. H., Grossman, H. B., Brauch, H., Pomer, S., Brooks, J. D., Issacs, W. B., Lerman, M. I., Zbar, B., and Linehan, W. M. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet., 7: 85-90, 1994.
6. Crossey, P. A., Foster, K., Richards, F. M., Phipps, M. E., Latif, F., Tory, K., Jones, M. H., Bentley, E., Kumar, R., Lerman, M. I., Zbar, B., Affara, N. A., Ferguson-Smith, M. A., and Maher, E. R. Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours. Hum. Genet., 93: 53-58, 1994.
7. Zeiger, M., Zbar, B., Keiser, H., Linehan, W. M., and Gnarra, J. R. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma. Genes Chromosomes Cancer 13: 151-156, 1995.
8. Tory, K., Brauch, H., Linehan, M., Barba, D., Oldfield, E., Filling-Katz, M., Seizinger, B., Nakamura, Y., White, R., Marshall, F. F., Lerman, M. I., and Zbar, B. Specific genetic change in tumors associated with von Hippel-Lindau disease. J. Natl. Cancer Inst. (Bethesda), 81: 1097-1101, 1989.
9. Knudson, A. G. Genetics of human cancer. Annu. Rev. Genet., 20: 231-251, 1986.
10. Levine, A. J. The tumor suppressor genes. Annu. Rev. Biochem., 62: 623-651, 1993.
11. Decker, H. H., Klauck, S. M., Lawrence, J. B., McNeil, J., Smith, D., Gemmill, R. M., Sandberg, A. A., Neumann, H. H. P., Simon, B., Green, J., and Seizinger, B. R. Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumor associated with von Hippel-Lindau syndrome (VHL). Cancer Genet. Cytogenet., 77: 1-13, 1994.
12. Shuin, T., Kondo, K., Torigoe, S., Kishida, T., Kubota, Y., Hosaka, M., Nagashima, Y., Kitamura, H., Latif, F., Zbar, B., Lerman, M. I., and Yao, M. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res., 54: 2852-2855, 1994.
13. Kanno, H., Kondo, K., Ito, S., Yamamoto, I., Fujii, S., Torigoe, S., Sakai, N., Hosaka, M., Masahiro, Y., Shuin, T., and Yao, M. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastoma. Cancer Res., 54: 4845-4847, 1994.
14. Oberstrass, J., Reifenberger, G., Reifenberger, J., Wechsler, W., and Collins, V. P. Mutation of the von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system. J. Pathol., 179: 151-156, 1996.
15. Tse, J. Y. M., Wong, J. H. C., Lo, K., Poon, W., Huang, D., P., and Ng, H. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas. Am. J. Clin. Pathol., 107: 459-466, 1997.
16. Vortmeyer, A. O., Gnarra, J. R., Emmert-Buck, M. R., Katz, D., Linehan, W. M., Oldfield, E. H., and Zhuang, Z. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum. Pathol., 28: 540-543, 1997.
17. Berkman, R. A., Merrill, M. J., Reinhold, W. C., Monacci, W. T., Saxena, A., Clark, W. C., Robertson, J. T., Ali, I. U., and Oldfield, E. H. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest., 91: 153-159, 1993.
18. Morii, K., Tanaka, R., Washiyama, K., Kumanishi, T., and Kuwano, R. Expression of vascular endothelial growth factor in capillary hemangioblastoma. Biochem. Biophys. Res. Commun., 194: 749-755, 1993.
19. Wizigmann-Voos, S., Breier, G., Risau, W., and Plate, K. H. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res., 55: 1358-1364, 1995.
20. Hatva, E., Böhling, T., Jääskeläinen, J., Persico, M. G., Haltia, M., and Alitalo, K. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am. J. Pathol., 148: 763-775, 1996.
21. Reifenberger, G., Reifenberger, J., Bilzer, T., Wechsler, W., and Collins, V. P. Coexpression of transforming growth factor-α and epidermal growth factor receptor in capillary hemangioblastomas of the central nervous system. Am. J. Pathol., 147: 245-250, 1995.
22. Rubinstein, L. J. Tumors of the Central Nervous System, Ed. 2. Washington, DC: AFIP, 1972.
23. Zhuang, Z., Bertheau, P., Emmert-Buck, M., Liotta, L., Gnarra, J., Linehan, W., and Lubensky, I. A. A microdissection technique for archival DNA analysis of specific cell populations in lesions less than one millimeter in size. Am. J. Pathol., 146: 620-625, 1995.
24. Herman, J. G., Latif, F., Weng, Y., Lerman, M., Zbar, B., Liu, S., Samid, D., Duan, D. R., Gnarra, J. R., Linehan, W. M., and Baylin, S. B. Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700-9704, 1994.
25. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.